It should be noted, however, that NfL is also ubiquitously increased in most neurodegenerative disorders [9] and a primary outcome in multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) drug efforts. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.